Search Results - "Bai, Hansong"

Refine Results
  1. 1

    Prognostic value of sarcopenia and inflammatory indices synergy in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy by Xiao, Ling, Liu, Yudi, Zhang, Xue, Nie, Xinyu, Bai, Hansong, Lyu, Jiahua, Li, Tao

    Published in BMC cancer (18-07-2024)
    “…Sarcopenia has been demonstrated to be adversely correlated with the prognosis of various cancers. Our study aimed to estimate the prognostic value of…”
    Get full text
    Journal Article
  2. 2

    Ginsenoside Rg3 increases gemcitabine sensitivity of pancreatic adenocarcinoma via reducing ZFP91 mediated TSPYL2 destabilization by Pan, Haixia, Yang, Linhan, Bai, Hansong, Luo, Jing, Deng, Ying

    Published in Journal of ginseng research (01-09-2022)
    “…Ginsenoside Rg3 and gemcitabine have mutual enhancing antitumor effects. However, the underlying mechanisms are not clear. This study explored the influence of…”
    Get full text
    Journal Article
  3. 3

    Establishment of predictive nomogram and web-based survival risk calculator for malignant pleural mesothelioma: A SEER database analysis by Chen, Sihao, Yu, Wanli, Shao, Shilong, Xiao, Jie, Bai, Hansong, Pu, Yu, Li, Mengxia

    Published in Frontiers in oncology (07-10-2022)
    “…Background Malignant pleural mesothelioma (MPM) is an uncommon condition with limited available therapies and dismal prognoses. The purpose of this work was to…”
    Get full text
    Journal Article
  4. 4

    Ginsenoside 20(S)-Rg3 reduces KIF20A expression and promotes CDC25A proteasomal degradation in epithelial ovarian cancer by Zhang, Rong, Li, Lei, Li, Huihui, Bai, Hansong, Suo, Yuping, Cui, Ju, Wang, Yingmei

    Published in Journal of ginseng research (2024)
    “…Ginsenoside 20(S)-Rg3 shows promising tumor-suppressive effects in ovarian cancer via inhibiting NF-κB signaling. This study aimed to explore the downstream…”
    Get full text
    Journal Article
  5. 5

    POLE and Mismatch Repair Status, Checkpoint Proteins and Tumor-Infiltrating Lymphocytes in Combination, and Tumor Differentiation: Identify Endometrial Cancers for Immunotherapy by Dong, Dandan, Lei, Huajiang, Liu, Duanya, Bai, Hansong, Yang, Yue, Tang, Baijie, Li, Ke, Liu, Juan, Xu, Gang, Xiao, Xue

    Published in Frontiers in oncology (19-03-2021)
    “…Although Polymerase-epsilon (POLE)-mutated and mismatch repair (MMR)-deficient endometrial cancers (ECs) are considered as promising candidates for…”
    Get full text
    Journal Article
  6. 6

    Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma by Bai, Hansong, Luo, Xing, Liao, Dongxu, Xiong, Wei, Zeng, Ming, Zheng, Bo

    Published in Technology in cancer research & treatment (01-01-2019)
    “…Objective: PTTG3P, which maps to chromosome 8q13.1, is a novel long noncoding RNA with oncogenic properties in cancers. In this study, we aimed to investigate…”
    Get full text
    Journal Article
  7. 7

    Ginsenoside Rg5 enhances the radiosensitivity of lung adenocarcinoma via reducing HSP90-CDC37 interaction and promoting client protein degradation by Bai, Hansong, Lyu, Jiahua, Nie, Xinyu, Kuang, Hao, Liang, Long, Jia, Hongyuan, Zhou, Shijie, Li, Churong, Li, Tao

    Published in Journal of pharmaceutical analysis (01-11-2023)
    “…Ginsenoside Rg5 is a rare ginsenoside showing promising tumor-suppressive effects. This study aimed to explore its radio-sensitizing effects and the underlying…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Ginsenoside Rg3 increases gemcitabine sensitivity of pancreatic adenocarcinoma via reducing ZFP91 mediated TSPYL2 destabilization by Pan, Haixia, Yang, Linhan, Bai, Hansong, Luo, Jing, Deng, Ying

    Published in Journal of ginseng research (2022)
    “…Background: Ginsenoside Rg3 and gemcitabine have mutual enhancing antitumor effects. However, the underlying mechanisms are not clear. This study explored the…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Post-treatment serum triglyceride: An effective biomarker for body fat mass and overall survival in esophageal squamous cell cancer patients treated with chemoradiotherapy by Lyu, Jiahua, Yang, Ningjing, Guan, Wang, Xiao, Ling, Nie, Xinyu, Liang, Long, Bai, Hansong, Li, Churong, Kuang, Hao, Wang, Xiao, Li, Tao

    Published in Frontiers in nutrition (Lausanne) (02-12-2022)
    “…Although lipids have been assessed for their possible roles in cancer survival prediction, studies on the association between serum triglyceride (TG) levels…”
    Get full text
    Journal Article
  12. 12

    Abstract 94: Pla2g4a: A new cell cycle related gene in patients with non-M3/NPM1 wildtype acute myeloid leukemia by Bai, Hansong, Ming, Zeng

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract In this study, we aimed to explore and validate the prognostic value of PLA2G4A expression in patients with non-M3/NPM1 wildtype (WT) acute myeloid…”
    Get full text
    Journal Article
  13. 13

    rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expression by Deng, Ying, Bai, Hansong, Hu, Honglin

    “…Single nucleotide polymorphism (SNP) rs11671784 is in the loop of pre-miR-27a and the G/A variation can significantly decrease mature miR-27a expression. This…”
    Get full text
    Journal Article
  14. 14

    PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer by Xia, Wei, Bai, Hansong, Deng, Ying, Yang, Yi

    Published in Journal of cellular and molecular medicine (01-11-2020)
    “…PLA2G16 is a member of the phospholipase family that catalyses the generation of lysophosphatidic acids (LPAs) and free fatty acids (FFAs) from phosphatidic…”
    Get full text
    Journal Article
  15. 15

    PLA2G4A Is a Potential Biomarker Predicting Shorter Overall Survival in Patients with Non-M3/ NPM1 Wildtype Acute Myeloid Leukemia by Bai, Hansong, Zhou, Mingxiu, Zeng, Ming, Han, Liying

    Published in DNA and cell biology (01-04-2020)
    “…In this study, we aimed at exploring and validating the prognostic value of expression in patients with non-M3/nucleophosmin ( ) wildtype (WT) acute myeloid…”
    Get more information
    Journal Article
  16. 16

    Sintilimab combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: A single-arm, multicenter, phase 2 trial by Lyu, Jiahua, Li, Tao, Liang, Long, Li, Churong, Jia, Hongyuan, Qi, Yunxiang, Zheng, Xiumei, Fan, Yu, Kuang, Hao, Bai, Hansong, Zhang, Wanli, Lu, Guangbing, Wang, Gan

    Published in Journal of clinical oncology (01-06-2024)
    “…e16120 Background: Sintilimab is a PD-1 inhibitor that is approved for the treatment of advanced esophageal squamous cell carcinoma, but its efficacy and…”
    Get full text
    Journal Article
  17. 17

    Twice-daily thoracic radiotherapy for patients with locally advanced or oligometastatic non-small cell lung cancer: A single-center observational study by Lyu, Jiahua, Liang, Long, Wang, Junchao, Wang, Qifeng, Wu, Lei, Wang, Yi, Wan, Gang, Jia, Hongyuan, Bai, Hansong, Li, Tao

    Published in Journal of clinical oncology (01-06-2022)
    “…e21070 Background: Radiotherapy is standard treatment for locally advanced or oligometastatic non-small cell lung cancer (NSCLC). Once-daily thoracic…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Nonlinear dynamic modeling and experimental study of full-composite cylindrical shells with a foam-filled cavity lattice core by Dong, Bocheng, Li, Hui, Li, Kaixiang, Zhang, Fei, Qiao, Zhou, Yang, Yao, Deng, Yichen, Wang, Shaoming, Bai, Hansong, Zhang, Haiyang, Cao, Hang, Wang, Xiangping, Zhou, Jin

    Published in Nonlinear dynamics (01-11-2023)
    “…A new full-composite cylindrical shell (FCCS) with a foam-filled cavity lattice core (FFCLC) is developed and prepared, and a nonlinear dynamic model…”
    Get full text
    Journal Article